Crospon secures €2.3m seed funding

Crospon, the Galway-based medical devices company, has secured €2.3m in seed funding.

This will be used for the development of the company’s system to enhance the diagnosis and treatment of GERD (Gastroesophageal Reflux Disorder).

This EndoFlip system is the first of a range of products Crospon is planning to bring to market. It is also looking to broaden its technology platform.